-
Something wrong with this record ?
Worldwide experience with a totally subcutaneous implantable defibrillator: early results from the EFFORTLESS S-ICD Registry
PD. Lambiase, C. Barr, DA. Theuns, R. Knops, P. Neuzil, JB. Johansen, M. Hood, S. Pedersen, S. Kääb, F. Murgatroyd, HL. Reeve, N. Carter, L. Boersma, . ,
Language English Country England, Great Britain
Document type Evaluation Study, Journal Article, Multicenter Study, Observational Study, Research Support, Non-U.S. Gov't
NLK
Free Medical Journals
from 1996 to 1 year ago
Open Access Digital Library
from 1996-01-01
- MeSH
- Time-to-Treatment MeSH
- Defibrillators, Implantable adverse effects standards statistics & numerical data MeSH
- Child MeSH
- Adult MeSH
- Prosthesis Implantation methods MeSH
- Quality of Life MeSH
- Middle Aged MeSH
- Humans MeSH
- Adolescent MeSH
- Young Adult MeSH
- Prospective Studies MeSH
- Registries MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Arrhythmias, Cardiac therapy MeSH
- Treatment Outcome MeSH
- Check Tag
- Child MeSH
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Adolescent MeSH
- Young Adult MeSH
- Male MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Evaluation Study MeSH
- Multicenter Study MeSH
- Observational Study MeSH
- Research Support, Non-U.S. Gov't MeSH
AIMS: The totally subcutaneous implantable-defibrillator (S-ICD) is a new alternative to the conventional transvenous ICD system to minimize intravascular lead complications. There are limited data describing the long-term performance of the S-ICD. This paper presents the first large international patient population collected as part of the EFFORTLESS S-ICD Registry. METHODS AND RESULTS: The EFFORTLESS S-ICD Registry is a non-randomized, standard of care, multicentre Registry designed to collect long-term, system-related, clinical, and patient reported outcome data from S-ICD implanted patients since June 2009. Follow-up data are systematically collected over 60-month post-implant including Quality of Life. The study population of 472 patients of which 241 (51%) were enrolled prospectively has a mean follow-up duration of 558 days (range 13-1342 days, median 498 days), 72% male, mean age of 49 ± 18 years (range 9-88 years), 42% mean left ventricular ejection fraction. Complication-free rates were 97 and 94%, at 30 and 360 days, respectively. Three hundred and seventeen spontaneous episodes were recorded in 85 patients during the follow-up period. Of these episodes, 169 (53%) received therapy, 93 being for Ventricular Tachycardia/Fibrillation (VT/VF). One patient died of recurrent VF and severe bradycardia. Regarding discrete VT/VF episodes, first shock conversion efficacy was 88% with 100% overall successful clinical conversion after a maximum of five shocks. The 360-day inappropriate shock rate was 7% with the vast majority occurring for oversensing (62/73 episodes), primarily of cardiac signals (94% of oversensed episodes). CONCLUSION: The first large cohort of real-world data from an International patient S-ICD population demonstrates appropriate system performance with clinical event rates and inappropriate shock rates comparable with those reported for conventional ICDs. Clinical trial registration URL: http://www.clinicaltrials.gov. Unique identifier NCT01085435.
Auckland City Hospital Auckland New Zealand
Boston Scientific Corporation St Paul MN USA
Cardiology Department Russells Hall Hospital Dudley UK
Department of Cardiology and Electrophysiology Academic Medical Center Amsterdam The Netherlands
Department of Cardiology Electrophysiology Section Odense University Hospital Odense Denmark
Department of Cardiology Homnolka Hospital Prague Czech Republic
Department of Clinical Electrophysiology Erasmus Medical Center Rotterdam The Netherlands
Division of Electrophysiology Campus Grosshadern University of Munich Munich Germany
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc15014449
- 003
- CZ-PrNML
- 005
- 20220126132402.0
- 007
- ta
- 008
- 150420s2014 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1093/eurheartj/ehu112 $2 doi
- 035 __
- $a (PubMed)24670710
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Lambiase, Pier D $u Cardiology Department, The Heart Hospital, Institute of Cardiovascular Science, University College London, 16-18 Westmoreland Street, W1G 8PH London, UK pier.lambiase@uclh.nhs.uk.
- 245 10
- $a Worldwide experience with a totally subcutaneous implantable defibrillator: early results from the EFFORTLESS S-ICD Registry / $c PD. Lambiase, C. Barr, DA. Theuns, R. Knops, P. Neuzil, JB. Johansen, M. Hood, S. Pedersen, S. Kääb, F. Murgatroyd, HL. Reeve, N. Carter, L. Boersma, . ,
- 520 9_
- $a AIMS: The totally subcutaneous implantable-defibrillator (S-ICD) is a new alternative to the conventional transvenous ICD system to minimize intravascular lead complications. There are limited data describing the long-term performance of the S-ICD. This paper presents the first large international patient population collected as part of the EFFORTLESS S-ICD Registry. METHODS AND RESULTS: The EFFORTLESS S-ICD Registry is a non-randomized, standard of care, multicentre Registry designed to collect long-term, system-related, clinical, and patient reported outcome data from S-ICD implanted patients since June 2009. Follow-up data are systematically collected over 60-month post-implant including Quality of Life. The study population of 472 patients of which 241 (51%) were enrolled prospectively has a mean follow-up duration of 558 days (range 13-1342 days, median 498 days), 72% male, mean age of 49 ± 18 years (range 9-88 years), 42% mean left ventricular ejection fraction. Complication-free rates were 97 and 94%, at 30 and 360 days, respectively. Three hundred and seventeen spontaneous episodes were recorded in 85 patients during the follow-up period. Of these episodes, 169 (53%) received therapy, 93 being for Ventricular Tachycardia/Fibrillation (VT/VF). One patient died of recurrent VF and severe bradycardia. Regarding discrete VT/VF episodes, first shock conversion efficacy was 88% with 100% overall successful clinical conversion after a maximum of five shocks. The 360-day inappropriate shock rate was 7% with the vast majority occurring for oversensing (62/73 episodes), primarily of cardiac signals (94% of oversensed episodes). CONCLUSION: The first large cohort of real-world data from an International patient S-ICD population demonstrates appropriate system performance with clinical event rates and inappropriate shock rates comparable with those reported for conventional ICDs. Clinical trial registration URL: http://www.clinicaltrials.gov. Unique identifier NCT01085435.
- 650 _2
- $a mladiství $7 D000293
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a senioři nad 80 let $7 D000369
- 650 _2
- $a srdeční arytmie $x terapie $7 D001145
- 650 _2
- $a dítě $7 D002648
- 650 _2
- $a defibrilátory implantabilní $x škodlivé účinky $x normy $x statistika a číselné údaje $7 D017147
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a prospektivní studie $7 D011446
- 650 _2
- $a implantace protézy $x metody $7 D019919
- 650 _2
- $a kvalita života $7 D011788
- 650 _2
- $a registrace $7 D012042
- 650 _2
- $a čas zasáhnout při rozvinutí nemoci $7 D061665
- 650 _2
- $a výsledek terapie $7 D016896
- 650 _2
- $a mladý dospělý $7 D055815
- 655 _2
- $a hodnotící studie $7 D023362
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a multicentrická studie $7 D016448
- 655 _2
- $a pozorovací studie $7 D064888
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Barr, Craig $u Cardiology Department, Russells Hall Hospital, Dudley, UK.
- 700 1_
- $a Theuns, Dominic A M J $u Department of Clinical Electrophysiology, Erasmus Medical Center, Rotterdam, The Netherlands.
- 700 1_
- $a Knops, Reinoud $u Department of Cardiology and Electrophysiology, Academic Medical Center, Amsterdam, The Netherlands.
- 700 1_
- $a Neuzil, Petr $u Department of Cardiology, Homnolka Hospital, Prague, Czech Republic.
- 700 1_
- $a Johansen, Jens Brock $u Department of Cardiology, Electrophysiology Section, Odense University Hospital, Odense, Denmark.
- 700 1_
- $a Hood, Margaret $u Auckland City Hospital, Auckland, New Zealand.
- 700 1_
- $a Pedersen, Susanne $u Center of Research on Psychology in Somatic Diseases, Department of Medical and Clinical Psychology, Tilburg University, Tilburg, The Netherlands Department of Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands.
- 700 1_
- $a Kääb, Stefan $u Division of Electrophysiology, Campus Grosshadern, University of Munich, Munich, Germany.
- 700 1_
- $a Murgatroyd, Francis D. $u King's College Hospital, London, UK. $7 xx0268928
- 700 1_
- $a Reeve, Helen L $u Boston Scientific Corporation, St Paul MN, USA.
- 700 1_
- $a Carter, Nathan $u Boston Scientific Corporation, St Paul MN, USA.
- 700 1_
- $a Boersma, Lucas $u St Antonius Ziekenhuis, Nieuwegein, The Netherlands.
- 700 1_
- $a ,
- 773 0_
- $w MED00009622 $t European heart journal $x 1522-9645 $g Roč. 35, č. 25 (2014), s. 1657-65
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/24670710 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20150420 $b ABA008
- 991 __
- $a 20220126132357 $b ABA008
- 999 __
- $a ok $b bmc $g 1072030 $s 897327
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2014 $b 35 $c 25 $d 1657-65 $i 1522-9645 $m European heart journal $n Eur Heart J $x MED00009622
- LZP __
- $a Pubmed-20150420